In these cancers, the tumor suppressive role of miR-145 is achieved, at least partially, through the regulation of cell cycle-related proteins such as CDK6 [47], CDK2 [48], and cyclin D1 [45], and direct targeting of oncogenes, including N-RAS and VEGF-A [49]. This evidence concerns the gene CDK6 and cancer.